CRISPR/cas13-mediated RNA targeting therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CRISPR/cas13-mediated RNA targeting therapy, covering 2025-03-17 to 2025-03-17. Get the full timeline:
Most recent: Clinical Trial Update: CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I) [EARLY_Phase 1]